{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:47:24Z","timestamp":1781174844274,"version":"3.54.1"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T00:00:00Z","timestamp":1695427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["D.O.NO.BT\/HRD\/35\/02\/2006; NO. BT\/RLF\/Re-entry 66\/2017; GAP-39"],"award-info":[{"award-number":["D.O.NO.BT\/HRD\/35\/02\/2006; NO. BT\/RLF\/Re-entry 66\/2017; GAP-39"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10096-023-04663-0","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T10:01:57Z","timestamp":1695463317000},"page":"1297-1315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Exploring and exploiting the host cell autophagy during Mycobacterium tuberculosis infection"],"prefix":"10.1007","volume":"42","author":[{"given":"Pavan Kumar","family":"Nagdev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja Kumari","family":"Agnivesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikanta","family":"Sau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4346-6567","authenticated-orcid":false,"given":"Nitin Pal","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,23]]},"reference":[{"key":"4663_CR1","unstructured":"World Health Organization (2021) Global tuberculosis report. Glob tuberkulosis Rep https:\/\/doi.org\/https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2021"},{"key":"4663_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S2213-2600(15)00063-6","volume":"3","author":"A Zumla","year":"2015","unstructured":"Zumla A, Chakaya J, Centis R, D\u2019Ambrosio L, Mwaba P, Bates M et al (2015) Tuberculosis treatment and management-an update on treatment regimens, trials, new drugs, and adjunct therapies. Lancet Respir Med 3:220\u2013234. https:\/\/doi.org\/10.1016\/S2213-2600(15)00063-6","journal-title":"Lancet Respir Med"},{"key":"4663_CR3","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1590\/s1806-37562016000000388","volume":"43","author":"MF Rabahi","year":"2017","unstructured":"Rabahi MF, Da Silva J\u00fanior JLR, Ferreira ACG, Tannus-Silva DGS, Conde MB (2017) Tuberculosis treatment. J Bras Pneumol 43:472\u2013486. https:\/\/doi.org\/10.1590\/s1806-37562016000000388","journal-title":"J Bras Pneumol"},{"key":"4663_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jb\/mvj162","volume":"140","author":"A Amano","year":"2006","unstructured":"Amano A, Nakagawa I, Yoshimori T (2006) Autophagy in innate immunity against intracellular bacteria. J. Biochem 140:161\u2013166. https:\/\/doi.org\/10.1093\/jb\/mvj162","journal-title":"J. Biochem"},{"key":"4663_CR5","doi-asserted-by":"publisher","unstructured":"Schmid U, Seidel H (2006) Autophagy in innate and adaptive immunity against intracellular pathogens. https:\/\/doi.org\/10.1007\/s00109-005-0014-4","DOI":"10.1007\/s00109-005-0014-4"},{"key":"4663_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.chom.2013.11.003","volume":"14","author":"TC Barnett","year":"2013","unstructured":"Barnett TC, Liebl D, Seymour LM, Gillen CM, Lim JY, Larock CN et al (2013) The globally disseminated M1T1 clone of group a streptococcus evades autophagy for intracellular replication. Cell Host Microbe 14:675\u2013682. https:\/\/doi.org\/10.1016\/j.chom.2013.11.003","journal-title":"Cell Host Microbe"},{"key":"4663_CR7","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1080\/15548627.2016.1226732","volume":"12","author":"Y Neumann","year":"2016","unstructured":"Neumann Y, Bruns SA, Rohde M, Prajsnar TK, Foster SJ, Schmitz I (2016) Intracellular Staphylococcus aureus eludes selective autophagy by activating a host cell kinase. Autophagy 12:2069\u20132084. https:\/\/doi.org\/10.1080\/15548627.2016.1226732","journal-title":"Autophagy"},{"key":"4663_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7554\/eLife.23905","volume":"6","author":"A Yang","year":"2017","unstructured":"Yang A, Pantoom S, Wu YW (2017) Elucidation of the anti-autophagy mechanism of the Legionella effector RavZ using semisynthetic LC3 proteins. Elife 6:1\u201323. https:\/\/doi.org\/10.7554\/eLife.23905","journal-title":"Elife"},{"key":"4663_CR9","doi-asserted-by":"publisher","unstructured":"Mu C (2009) Macroautophagy in immunity and tolerance:615\u2013620. https:\/\/doi.org\/10.1111\/j.1600-0854.2009.00883.x","DOI":"10.1111\/j.1600-0854.2009.00883.x"},{"key":"4663_CR10","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.4049\/jimmunol.176.5.3019","volume":"176","author":"N Banaiee","year":"2006","unstructured":"Banaiee N, Kincaid EZ, Buchwald U, Jacobs WR, Ernst JD (2006) Potent inhibition of macrophage responses to IFN-\u03b3 by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 176:3019\u20133027. https:\/\/doi.org\/10.4049\/jimmunol.176.5.3019","journal-title":"J Immunol"},{"key":"4663_CR11","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1084\/jem.20051782","volume":"202","author":"A Bafica","year":"2005","unstructured":"Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A (2005) TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 202:1715\u20131724. https:\/\/doi.org\/10.1084\/jem.20051782","journal-title":"J Exp Med"},{"issue":"134","key":"4663_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1084\/jem.134.3.713","volume":"1","author":"JA Armstrong","year":"1971","unstructured":"Armstrong JA, Hart D (1971) Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 1(134):713\u2013740.\u00a0https:\/\/doi.org\/http:\/\/rupress.org\/jem\/article-pdf\/134\/3\/713\/1415906\/713","journal-title":"J Exp Med"},{"key":"4663_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.200106049","volume":"154","author":"RA Fratti","year":"2001","unstructured":"Fratti RA, Backer JM, Gruenberg J, Corvera S, Deretic V (2001) Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol 154:631\u2013644. https:\/\/doi.org\/10.1083\/jcb.200106049","journal-title":"J Cell Biol"},{"key":"4663_CR14","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1073\/pnas.0737613100","volume":"100","author":"RA Fratti","year":"2003","unstructured":"Fratti RA, Chua J, Vergne I, Deretic V (2003) Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest. Proc Natl Acad Sci U S A 100:5437\u20135442. https:\/\/doi.org\/10.1073\/pnas.0737613100","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"4663_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/J.SMIM.2014.09.009","volume":"1","author":"IM Orme","year":"2014","unstructured":"Orme IM, Basaraba RJ (2014) The formation of the granuloma in tuberculosis infection. Semin Immunol 1(26):601\u2013609. https:\/\/doi.org\/10.1016\/J.SMIM.2014.09.009","journal-title":"Semin Immunol"},{"key":"4663_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2012.00411","volume":"3","author":"S Ehlers","year":"2012","unstructured":"Ehlers S, Schaible UE (2012) The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front Immunol 3:1\u201310. https:\/\/doi.org\/10.3389\/fimmu.2012.00411","journal-title":"Front Immunol"},{"key":"4663_CR17","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1128\/IAI.69.7.4195-4201.2001","volume":"69","author":"JL Flynn","year":"2001","unstructured":"Flynn JL, Chan J (2001) Tuberculosis: latency and reactivation. Infect Immun 69:4195\u20134201. https:\/\/doi.org\/10.1128\/IAI.69.7.4195-4201.2001","journal-title":"Infect Immun"},{"issue":"217","key":"4663_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/J.IMBIO.2011.07.008","volume":"1","author":"A Gupta","year":"2012","unstructured":"Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S (2012) Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 1(217):363\u2013374. https:\/\/doi.org\/10.1016\/J.IMBIO.2011.07.008","journal-title":"Immunobiology"},{"key":"4663_CR19","doi-asserted-by":"crossref","unstructured":"Mizushima N. A brief history of autophagy from cell biology to physiology and disease. Nat Cell Biol 2018 205 2018 ;20:521\u20137. https:\/\/www.nature.com\/articles\/s41556-018-0092-5","DOI":"10.1038\/s41556-018-0092-5"},{"key":"4663_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/dna.2014.2745","volume":"34","author":"CF Bento","year":"2015","unstructured":"Bento CF, Empadinhas N, Mendes V (2015) Autophagy in the fight against tuberculosis. DNA Cell Biol. 34:228\u2013242. https:\/\/doi.org\/10.1089\/dna.2014.2745","journal-title":"DNA Cell Biol."},{"key":"4663_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1101\/sqb.2011.76.011023","volume":"76","author":"N Mizushima","year":"2011","unstructured":"Mizushima N (2011) Autophagy in protein and organelle turnover. Cold Spring Harb Symp Quant Biol 76:397\u2013402. https:\/\/doi.org\/10.1101\/sqb.2011.76.011023","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"4663_CR22","unstructured":"Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. https:\/\/home.liebertpub.com\/ars;20:46073.doi:https:\/\/www.liebertpub.com"},{"issue":"108","key":"4663_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/J.BULCAN.2020.11.004","volume":"1","author":"W Cao","year":"2021","unstructured":"Cao W, Li J, Yang K, Cao D (2021) An overview of autophagy: mechanism, regulation and research progress. Bull Cancer 1(108):304\u2013322. https:\/\/doi.org\/10.1016\/J.BULCAN.2020.11.004","journal-title":"Bull Cancer"},{"key":"4663_CR24","doi-asserted-by":"crossref","unstructured":"Klionsky DJ, Cregg JM, Dunn WA Jr, Emr SD, Sakai Y, Sandoval IV, Sibirny A, Subramani S, Thumm M, Veenhuis M, Ohsumi Y (2003) A unified nomenclature for yeast autophagy-related genes. Dev Cell 5:539\u201345","DOI":"10.1016\/S1534-5807(03)00296-X"},{"issue":"19","key":"4663_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"196","author":"I Dikic","year":"2018","unstructured":"Dikic I, Elazar Z (2018) Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol 196(19):349\u2013364.\u00a0https:\/\/doi.org\/https:\/\/www.nature.com\/articles\/s41580-018-0003-4","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4663_CR26","first-page":"22284","volume":"273","author":"Y Ohsumi","year":"1998","unstructured":"Ohsumi Y (1998) Apg14p and Apg6 \/ Vps30p form a protein complex essential for autophagy in the yeast. Saccharomyces cerevisiae *. 273:22284\u201322291","journal-title":"Saccharomyces cerevisiae *."},{"key":"4663_CR27","doi-asserted-by":"publisher","unstructured":"Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh B et al (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. 8. https:\/\/doi.org\/10.1038\/ncb1426","DOI":"10.1038\/ncb1426"},{"key":"4663_CR28","doi-asserted-by":"publisher","unstructured":"Proikas-cezanne T, Waddell S, Gaugel A, Frickey T, Lupas A, Nordheim A (2004) WIPI-1 a ( WIPI49 ), a member of the novel 7-bladed WIPI protein family , is aberrantly expressed in human cancer and is linked to starvation-induced autophagy:9314\u20139325. https:\/\/doi.org\/10.1038\/sj.onc.1208331","DOI":"10.1038\/sj.onc.1208331"},{"key":"4663_CR29","doi-asserted-by":"publisher","unstructured":"Polson HEJ, Lartigue J (2010) De, Rigden DJ, Reedijk M, Clague MJ, Tooze SA, et al. Mammalian Atg18 ( WIPI2 ) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. 8627. https:\/\/doi.org\/10.4161\/auto.6.4.11863","DOI":"10.4161\/auto.6.4.11863"},{"key":"4663_CR30","doi-asserted-by":"publisher","unstructured":"Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, Klionsky DJ, Ohsumi M, Ohsumi Y (1998) A protein conjugation system essential for autophagy. Nature 395:395\u2013398. https:\/\/doi.org\/10.1038\/26506","DOI":"10.1038\/26506"},{"key":"4663_CR31","doi-asserted-by":"publisher","unstructured":"Mizushima N, Noda T, Ohsumi Y (1999) Apg16p is required for the function of the Apg12p\u2013Apg5p conjugate in the yeast autophagy pathway. EMBO J 18(14):3888\u20133896. https:\/\/doi.org\/10.1093\/emboj\/18.14.3888","DOI":"10.1093\/emboj\/18.14.3888"},{"key":"4663_CR32","doi-asserted-by":"publisher","unstructured":"Death C, Dikic I (2018) Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/s41580-018-0003-4","DOI":"10.1038\/s41580-018-0003-4"},{"key":"4663_CR33","doi-asserted-by":"crossref","unstructured":"Weidberg H, Shvets E, Shpilka T, Shimron F, Shinder V, Elazar Z LC3 and GATE-16\/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J 29:1792\u20131802 https:\/\/onlinelibrary.wiley.com","DOI":"10.1038\/emboj.2010.74"},{"issue":"147","key":"4663_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.147.2.435","volume":"18","author":"T Kirisako","year":"1999","unstructured":"Kirisako T, Baba M, Ishihara N, Miyazawa K, Ohsumi M, Yoshimori T et al (1999) Formation process of autophagosome is traced with Apg8\/Aut7p in yeast. J Cell Biol 18(147):435\u2013446 https:\/\/doi.org\/http:\/\/www.jcb.orgdoi:%2010.1083\/JCB.147.2.435","journal-title":"J Cell Biol"},{"key":"4663_CR35","doi-asserted-by":"publisher","unstructured":"Taylor P (2011) a n d e s i o s c i e n c e o n o t d i s t r i b u t e. https:\/\/doi.org\/10.4161\/auto.7.8.15860","DOI":"10.4161\/auto.7.8.15860"},{"key":"4663_CR36","doi-asserted-by":"publisher","unstructured":"Singh P, Subbian S (2018) Harnessing the mTOR pathway for tuberculosis treatment. 9:1\u201311. https:\/\/doi.org\/10.3389\/fmicb.2018.00070","DOI":"10.3389\/fmicb.2018.00070"},{"key":"4663_CR37","doi-asserted-by":"publisher","unstructured":"Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y et al (2009) Nutrient-dependent mTORC1 association with the ULK1 \u2013 Atg13 \u2013 FIP200 complex required for autophagy. 20:1981\u20131991. https:\/\/doi.org\/10.1091\/mbc.E08","DOI":"10.1091\/mbc.E08"},{"key":"4663_CR38","doi-asserted-by":"publisher","unstructured":"Ha J, Guan K, Kim J. Dept , of Biochemistry and Molecular Biology , Medical Research Center and Biomedical Dept . of Oral Biochemistry and Molecular Biology , Research Center for Tooth and. Mol. Aspects Med. 2015; https:\/\/doi.org\/10.1016\/j.mam.2015.08.002","DOI":"10.1016\/j.mam.2015.08.002"},{"key":"4663_CR39","doi-asserted-by":"publisher","unstructured":"Nascimbeni AC, Giordano F, Codogno P, Morel E, Dupont N, Grasso D et al (2018) ER \u2013 plasma membrane contact sites contribute to autophagosome biogenesis by regulation of local PI 3 P synthesis. 36:2018\u20132033. https:\/\/doi.org\/10.15252\/embj.201797006","DOI":"10.15252\/embj.201797006"},{"key":"4663_CR40","doi-asserted-by":"publisher","unstructured":"Strong LM, Chang C, Riley JF, Boecker CA, Flower TG, Buffalo CZ, Ren X, Stavoe AK, Holzbaur EL, Hurley JH (2021) Structural basis for membrane recruitment of ATG16L1 by WIPI2 in autophagy. Elife 10:e70372. https:\/\/doi.org\/10.7554\/eLife.70372","DOI":"10.7554\/eLife.70372"},{"key":"4663_CR41","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1080\/15548627.2019.1618100","volume":"15","author":"AH Lystad","year":"2019","unstructured":"Lystad AH, Carlsson SR, Simonsen A, Carlsson SR (2019) Toward the function of mammalian ATG12 \u2013 ATG5- ATG16L1 complex in autophagy and related processes and related processes. Autophagy 15:1485\u20131486. https:\/\/doi.org\/10.1080\/15548627.2019.1618100","journal-title":"Autophagy"},{"key":"4663_CR42","doi-asserted-by":"publisher","unstructured":"Furuta N, Fujita N, Noda T, Yoshimori T, Amano A (2010) Combinational soluble N -ethylmaleimide-sensitive factor attachment protein receptor proteins VAMP8 and Vti1b mediate fusion of antimicrobial and canonical autophagosomes with lysosomes. 21:1001\u20131010. https:\/\/doi.org\/10.1091\/mbc.E09","DOI":"10.1091\/mbc.E09"},{"key":"4663_CR43","doi-asserted-by":"publisher","unstructured":"Taylor P Syntaxin 17:4\u20137. https:\/\/doi.org\/10.4161\/auto.24109","DOI":"10.4161\/auto.24109"},{"key":"4663_CR44","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.cell.2012.11.001","volume":"151","author":"E Itakura","year":"2012","unstructured":"Itakura E, Kishi-itakura C, Mizushima N (2012) The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes \/ lysosomes. Cell 151:1256\u20131269. https:\/\/doi.org\/10.1016\/j.cell.2012.11.001","journal-title":"Cell"},{"key":"4663_CR45","doi-asserted-by":"publisher","unstructured":"Morelli E, Ginefra P, Mastrodonato V, Galina V, Rusten TE, Bilder D et al (2014) Multiple functions of the SNARE protein Snap29 in autophagy , endocytic , and exocytic trafficking during epithelial formation in Drosophila Multiple functions of the SNARE protein Snap29 in autophagy , endocytic , and exocytic trafficking during epithe. 8627. https:\/\/doi.org\/10.4161\/15548627.2014.981913","DOI":"10.4161\/15548627.2014.981913"},{"key":"4663_CR46","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.bbamcr.2012.11.018","volume":"1833","author":"JMT Hyttinen","year":"2013","unstructured":"Hyttinen JMT, Niittykoski M, Salminen A, Kaarniranta K (2013) Biochimica et Biophysica Acta Maturation of autophagosomes and endosomes\u00a0: a key role for Rab7. BBA - Mol Cell Res 1833:503\u2013510. https:\/\/doi.org\/10.1016\/j.bbamcr.2012.11.018","journal-title":"BBA - Mol Cell Res"},{"key":"4663_CR47","doi-asserted-by":"publisher","unstructured":"Armstrong JA, Hart PD (1971) Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 134(3):713\u2013740. https:\/\/doi.org\/10.1084\/jem.134.3.713","DOI":"10.1084\/jem.134.3.713"},{"key":"4663_CR48","first-page":"1274","volume":"178","author":"GG Mahairas","year":"1996","unstructured":"Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK (1996) Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis 178:1274\u20131282","journal-title":"bovis"},{"key":"4663_CR49","doi-asserted-by":"publisher","unstructured":"Peng X, Sun J (2015) Mechanism of ESAT-6 membrane interaction and its roles in pathogenesis of Mycobacterium tuberculosis. Toxicon. https:\/\/doi.org\/10.1016\/j.toxicon.2015.10.003","DOI":"10.1016\/j.toxicon.2015.10.003"},{"key":"4663_CR50","doi-asserted-by":"publisher","unstructured":"Essafi M. i v o r l a n o v l. 2018.\u00a0https:\/\/doi.org\/10.3389\/fcimb.2018.00327","DOI":"10.3389\/fcimb.2018.00327"},{"key":"4663_CR51","doi-asserted-by":"publisher","unstructured":"Yang S, Li F, Jia S, Zhang K, Jiang W, Shang Y et al (2015) Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes apoptosis of macrophages via targeting the microRNA155 \u2013 SOCS1 interaction. 400042:1276\u20131288. https:\/\/doi.org\/10.1159\/000373950","DOI":"10.1159\/000373950"},{"key":"4663_CR52","doi-asserted-by":"publisher","unstructured":"Puri RV, Reddy PV, Tyagi AK (2013) Secreted acid phosphatase ( SapM ) of Mycobacterium tuberculosis is indispensable for arresting phagosomal maturation and growth of the pathogen in guinea pig tissues. 8. https:\/\/doi.org\/10.1371\/journal.pone.0070514","DOI":"10.1371\/journal.pone.0070514"},{"key":"4663_CR53","doi-asserted-by":"publisher","unstructured":"Chauhan P, Reddy PV, Singh R, Jaisinghani N, Gandotra S (2013) Secretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs. 8:1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0077930","DOI":"10.1371\/journal.pone.0077930"},{"key":"4663_CR54","doi-asserted-by":"publisher","unstructured":"Festjens N, Bogaert P, Batni A, Houthuys E, Plets E, Vanderschaeghe D et al (2011) Disruption of the SapM locus in Mycobacterium bovis BCG improves its protective efficacy as a vaccine against M. tuberculosis:222\u2013234. https:\/\/doi.org\/10.1002\/emmm.201000125","DOI":"10.1002\/emmm.201000125"},{"key":"4663_CR55","doi-asserted-by":"publisher","unstructured":"Fernandez-soto P, Bruce AJE, Fielding AJ, Cavet JS, Tabernero L (2019) Mechanism of catalysis and inhibition of Mycobacterium tuberculosis SapM , implications for the development of novel antivirulence drugs. Sci Rep:1\u201314. https:\/\/doi.org\/10.1038\/s41598-019-46731-6","DOI":"10.1038\/s41598-019-46731-6"},{"key":"4663_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2021.1938912","volume":"00","author":"P Ge","year":"2021","unstructured":"Ge P, Lei Z, Yu Y, Lu Z, Qiang L, Chai Q et al (2021) M . tuberculosis PknG manipulates host autophagy flux to promote pathogen intracellular survival. Autophagy 00:1\u201319. https:\/\/doi.org\/10.1080\/15548627.2021.1938912","journal-title":"Autophagy"},{"key":"4663_CR57","doi-asserted-by":"publisher","unstructured":"Khan MZ, Bhaskar A, Upadhyay S, Kumari P, Rajmani RS, Jain P et al (2017) Protein kinase G confers survival advantage to Mycobacterium tuberculosis during latency like conditions:1\u201328. https:\/\/doi.org\/10.1074\/jbc.M117.797563","DOI":"10.1074\/jbc.M117.797563"},{"key":"4663_CR58","doi-asserted-by":"publisher","unstructured":"Khan MZ, Nandicoori VK (2021) Deletion of pknG abates reactivation of latent mycobacterium tuberculosis in mice. Antimicrob Agents Chemother 65(4):10\u2013128. https:\/\/doi.org\/10.1128\/aac.02095-20","DOI":"10.1128\/aac.02095-20"},{"key":"4663_CR59","doi-asserted-by":"publisher","unstructured":"Lima A, Leyva A, Rivera B, Magdalena M, Gil M (2021) Cascioferro A, et al, Proteome remodeling in the Mycobacterium tuberculosis PknG knockout\u00a0: molecular evidence for the role of this kinase in cell envelope biogenesis and hypoxia response. 244. https:\/\/doi.org\/10.1016\/j.jprot.2021.104276","DOI":"10.1016\/j.jprot.2021.104276"},{"key":"4663_CR60","doi-asserted-by":"publisher","unstructured":"Samuel LP, Song C, Wei J, Roberts EA, Dahl JL (2007) Barry CE, et al, Expression , production and release of the Eis protein by Mycobacterium tuberculosis during infection of macrophages and its effect on cytokine secretion Printed in Great Britain:529\u2013540. https:\/\/doi.org\/10.1099\/mic.0.2006\/002642-0","DOI":"10.1099\/mic.0.2006\/002642-0"},{"key":"4663_CR61","doi-asserted-by":"publisher","unstructured":"Shin D, Jeon B, Lee H, Jin HS, Yuk J, Song C et al (2010) Mycobacterium tuberculosis Eis regulates autophagy , inflammation , and cell death through redox-dependent signaling. 6. https:\/\/doi.org\/10.1371\/journal.ppat.1001230","DOI":"10.1371\/journal.ppat.1001230"},{"key":"4663_CR62","doi-asserted-by":"publisher","unstructured":"Pan Q, Zhao F, Ye B (2018) Eis , a novel family of arylalkylamine. Sci Rep:1\u20138. https:\/\/doi.org\/10.1038\/s41598-018-20802-6","DOI":"10.1038\/s41598-018-20802-6"},{"key":"4663_CR63","doi-asserted-by":"publisher","DOI":"10.1021\/bi3004473","volume-title":"Aminoglycoside multiacetylating activity of the enhanced intracellular survival protein from Mycobacterium smegmatis and its inhibition","author":"W Chen","year":"2012","unstructured":"Chen W, Green KD, Tsodikov O V, Garneau-tsodikova S. Aminoglycoside multiacetylating activity of the enhanced intracellular survival protein from Mycobacterium smegmatis and its inhibition. 2012;"},{"key":"4663_CR64","doi-asserted-by":"publisher","unstructured":"Zaunbrecher MA, Sikes Jr RD, Metchock B, Shinnick TM, Posey JE (2009) Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci 106(47):20004\u201320009. https:\/\/doi.org\/10.1073\/pnas.0907925106","DOI":"10.1073\/pnas.0907925106"},{"key":"4663_CR65","doi-asserted-by":"publisher","unstructured":"Chen W, Biswas T, Porter VR, Tsodikov OV, Garneau-tsodikova S (2011) Unusual regioversatility of acetyltransferase Eis , a cause of drug resistance in XDR-TB. 108:1\u20135. https:\/\/doi.org\/10.1073\/pnas.1105379108\/-\/DCSupplemental.www.pnas.org\/cgi\/doi\/10.1073\/pnas.1105379108","DOI":"10.1073\/pnas.1105379108\/-\/DCSupplemental.www.pnas.org\/cgi\/doi\/10.1073\/pnas.1105379108"},{"key":"4663_CR66","doi-asserted-by":"publisher","first-page":"19371","DOI":"10.1073\/pnas.1109201108","volume":"108","author":"D Wong","year":"2011","unstructured":"Wong D, Bach H, Sun J, Hmama Z, Av-Gay Y (2011) Mycobacterium tuberculosis protein tyrosine phosphatase (PtpA) excludes host vacuolar-H +-ATPase to inhibit phagosome acidification. Proc Natl Acad Sci U S A 108:19371\u201319376. https:\/\/doi.org\/10.1073\/pnas.1109201108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4663_CR67","doi-asserted-by":"publisher","unstructured":"Cole S, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry Iii CE, Tekaia F (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 396(6707):190. https:\/\/doi.org\/10.1038\/24206","DOI":"10.1038\/24206"},{"key":"4663_CR68","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.chom.2008.03.008","volume":"3","author":"H Bach","year":"2008","unstructured":"Bach H, Papavinasasundaram KG, Wong D, Hmama Z, Av-Gay Y (2008) Mycobacterium tuberculosis virulence is mediated by PtpA dephosphorylation of human vacuolar protein sorting 33B. Cell Host Microbe 3:316\u2013322. https:\/\/doi.org\/10.1016\/j.chom.2008.03.008","journal-title":"Cell Host Microbe"},{"key":"4663_CR69","doi-asserted-by":"publisher","unstructured":"Wang J, Ge P, Qiang L, Tian F, Zhao D, Chai Q et al The mycobacterial phosphatase PtpA regulates the expression of host genes and promotes cell proliferation. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-017-00279-z","DOI":"10.1038\/s41467-017-00279-z"},{"key":"4663_CR70","doi-asserted-by":"publisher","unstructured":"Brien JO, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis , mechanisms of actions , and circulation. 9:1\u201312. https:\/\/doi.org\/10.3389\/fendo.2018.00402","DOI":"10.3389\/fendo.2018.00402"},{"key":"4663_CR71","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.molimm.2011.02.001","volume":"48","author":"Y Liu","year":"2011","unstructured":"Liu Y, Wang X, Jiang J, Cao Z, Yang B, Cheng X (2011) Modulation of T cell cytokine production by miR-144 * with elevated expression in patients with pulmonary tuberculosis. Mol Immunol 48:1084\u20131090. https:\/\/doi.org\/10.1016\/j.molimm.2011.02.001","journal-title":"Mol Immunol"},{"key":"4663_CR72","doi-asserted-by":"publisher","first-page":"107286","DOI":"10.1016\/j.intimp.2020.107286","volume":"91","author":"J Cui","year":"2021","unstructured":"Cui J, Li Z, Cui K, Gao Y, Zhang B, Niu J et al (2021) International immunopharmacology microRNA-20a-3p regulates the host immune response to facilitate the mycobacterium tuberculosis infection by targeting IKK \u03b2 \/ NF- \u03ba B pathway. Int Immunopharmacol 91:107286. https:\/\/doi.org\/10.1016\/j.intimp.2020.107286","journal-title":"Int Immunopharmacol"},{"key":"4663_CR73","doi-asserted-by":"publisher","unstructured":"Guo L, Zhao J, Qu Y, Yin R, Gao Q, Ding S (2016) MicroRNA-20a inhibits autophagic process by targeting ATG7 and ATG16L1 and favors mycobacterial survival in macrophage cells. 6:1\u201312. https:\/\/doi.org\/10.3389\/fcimb.2016.00134","DOI":"10.3389\/fcimb.2016.00134"},{"key":"4663_CR74","doi-asserted-by":"publisher","unstructured":"Ding S, Qu Y, Yang S, Xu G (2019) Novel miR-1958 promotes Mycobacterium tuberculosis survival in RAW264. 7 cells by inhibiting autophagy via Atg5.\u00a0J Microbiol Biotechnol 29(6):989\u2013998.\u00a0https:\/\/doi.org\/10.4014\/jmb.1811.11062","DOI":"10.4014\/jmb.1811.11062"},{"key":"4663_CR75","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2019.01.004","volume":"337","author":"Y Qu","year":"2019","unstructured":"Qu Y, Ding S, Ma Z, Jiang D, Xu X, Zhang Y (2019) MiR-129-3p favors intracellular BCG survival in RAW264 . 7 cells by inhibiting autophagy via Atg4b. Cell Immunol 337:22\u201332. https:\/\/doi.org\/10.1016\/j.cellimm.2019.01.004","journal-title":"Cell Immunol"},{"key":"4663_CR76","doi-asserted-by":"publisher","unstructured":"Chen Z, Wang T, Liu Z, Zhang G, Wang J, Feng S et al (2015) Inhibition of autophagy by miR-30A induced by Mycobacteria tuberculosis as a possible mechanism of immune escape in human macrophages:420\u2013424. https:\/\/doi.org\/10.7883\/yoken.JJID.2014.466","DOI":"10.7883\/yoken.JJID.2014.466"},{"key":"4663_CR77","doi-asserted-by":"publisher","unstructured":"Kumar R, Gupta P, Jana K, Gupta UD, Ghosh Z (2017) EBP \u03b2 regulate innate immune signaling , the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection. 1\u201329. https:\/\/doi.org\/10.1371\/journal.ppat.1006410","DOI":"10.1371\/journal.ppat.1006410"},{"key":"4663_CR78","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ni.3434","volume":"17","author":"M Ouimet","year":"2016","unstructured":"Ouimet M, Koster S, Sakowski E, Ramkhelawon B, Van Solingen C, Oldebeken S et al (2016) Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism. Nat Immunol 17:677\u2013686. https:\/\/doi.org\/10.1038\/ni.3434","journal-title":"Nat Immunol"},{"key":"4663_CR79","doi-asserted-by":"publisher","unstructured":"Liu F, Chen J, Wang P, Li H, Zhou Y, Liu H et al Associated autophagy. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-018-06836-4","DOI":"10.1038\/s41467-018-06836-4"},{"key":"4663_CR80","doi-asserted-by":"publisher","unstructured":"Strong EJ, Wang J, Ng TW, Porcelli SA, Lee S Mycobacterium tuberculosis PPE51 inhibits autophagy by suppressing Toll-like receptor 2-dependent signaling. MBio 13. https:\/\/doi.org\/10.1128\/mbio.02974-21","DOI":"10.1128\/mbio.02974-21"},{"key":"4663_CR81","doi-asserted-by":"publisher","unstructured":"Shariq M, Quadir N, Sharma N, Singh J, Sheikh JA, Khubaib M et al (2021) Mycobacterium tuberculosis RipA dampens TLR4-mediated host protective response using a multi-pronged approach involving autophagy , apoptosis , metabolic repurposing , and immune modulation. 12:1\u201319. https:\/\/doi.org\/10.3389\/fimmu.2021.636644","DOI":"10.3389\/fimmu.2021.636644"},{"key":"4663_CR82","doi-asserted-by":"publisher","unstructured":"Sinha S, Gupta G, Biswas S, Gupta K, Singh PP, Jain R et al (2022) Coronin-1 levels in patients with tuberculosis:866\u2013870. https:\/\/doi.org\/10.4103\/ijmr.IJMR","DOI":"10.4103\/ijmr.IJMR"},{"key":"4663_CR83","doi-asserted-by":"publisher","unstructured":"Mori M, Mode R, Pieters J (2018) From phagocytes to immune defense\u00a0: roles for coronin proteins in Dictyostelium and mammalian immunity. 8:1\u20137. https:\/\/doi.org\/10.3389\/fcimb.2018.00077","DOI":"10.3389\/fcimb.2018.00077"},{"key":"4663_CR84","doi-asserted-by":"publisher","unstructured":"Jayachandran R, Sundaramurthy V, Combaluzier B, Mueller P, Korf H, Huygen K et al (2007) Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin:37\u201350. https:\/\/doi.org\/10.1016\/j.cell.2007.04.043","DOI":"10.1016\/j.cell.2007.04.043"},{"key":"4663_CR85","doi-asserted-by":"publisher","unstructured":"Seto S, Tsujimura K, Koide Y (2012) Coronin-1a inhibits autophagosome formation around Mycobacterium tuberculosis -containing phagosomes and assists mycobacterial survival in macrophages. 14:710\u2013727. https:\/\/doi.org\/10.1111\/j.1462-5822.2012.01754.x","DOI":"10.1111\/j.1462-5822.2012.01754.x"},{"key":"4663_CR86","doi-asserted-by":"publisher","unstructured":"Turner J, Torrelles JB (2018) Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis. https:\/\/doi.org\/10.1093\/femspd\/fty026\/4953419","DOI":"10.1093\/femspd\/fty026\/4953419"},{"key":"4663_CR87","doi-asserted-by":"publisher","unstructured":"Correia-Neves M, Fr\u00f6berg G, Korshun L, Viegas S, Vaz P, Ramanlal N et al Biomarkers for tuberculosis: the case for lipoarabinomannan. [cited 2022 1]; http:\/\/ow.ly\/FyCs30n4uFEdoi. https:\/\/doi.org\/10.1183\/23120541.00115-2018","DOI":"10.1183\/23120541.00115-2018"},{"key":"4663_CR88","doi-asserted-by":"publisher","first-page":"101265","DOI":"10.1016\/j.jbc.2021.101265","volume":"297","author":"P De","year":"2021","unstructured":"De P, Amin AG, Flores D, Simpson A, Dobos K, Chatterjee D (2021) Structural implications of lipoarabinomannan glycans from global clinical isolates in diagnosis of Mycobacterium tuberculosis infection. J Biol Chem 297:101265. https:\/\/doi.org\/10.1016\/j.jbc.2021.101265","journal-title":"J Biol Chem"},{"key":"4663_CR89","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1128\/IAI.01549-07","volume":"76","author":"A Welin","year":"2008","unstructured":"Welin A, Winberg ME, Abdalla H, S\u00e4rndahl E, Rasmusson B, Stendahl O et al (2008) Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block. Infect Immun 76:2882\u20132887. https:\/\/doi.org\/10.1128\/IAI.01549-07","journal-title":"Infect Immun"},{"key":"4663_CR90","doi-asserted-by":"publisher","unstructured":"Liu H, Gui X, Chen S, Fu W, Li X, Xiao T et al (2022) Structural variability of lipoarabinomannan modulates innate immune responses within infected alveolar epithelial cells. Cells:11. https:\/\/doi.org\/10.3390\/cells11030361","DOI":"10.3390\/cells11030361"},{"key":"4663_CR91","doi-asserted-by":"publisher","unstructured":"Sibley LD, Hunter SW, Brennan PJ, Krahenbuhl JL (1988) Mycobacterial hpoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect fmmun 56:1232\u20131236. https:\/\/doi.org\/10.1128\/iai.56.5.1232-1236.1988","DOI":"10.1128\/iai.56.5.1232-1236.1988"},{"key":"4663_CR92","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1128\/iai.59.5.1755-1761.1991","volume":"59","author":"J Chan","year":"1991","unstructured":"Chan J, Fan X, Hunter SW, Brennan PJ, Bloom BR (1991) Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect Immun 59:1755\u20131761. https:\/\/doi.org\/10.1128\/iai.59.5.1755-1761.1991","journal-title":"Infect Immun"},{"key":"4663_CR93","doi-asserted-by":"publisher","unstructured":"Sengupta S, Nayak B, Meuli M, Sander P, Mishra S (2021) Mycobacterium tuberculosis phosphoribosyltransferase promotes bacterial survival in macrophages by inducing histone hypermethylation in autophagy-related genes. 11:1\u201313. https:\/\/doi.org\/10.3389\/fcimb.2021.676456","DOI":"10.3389\/fcimb.2021.676456"},{"key":"4663_CR94","doi-asserted-by":"publisher","unstructured":"Padhi A, Pattnaik K, Biswas M, Jagadeb M, Behera A, Alerts E (2019) Mycobacterium tuberculosis LprE suppresses TLR2-dependent cathelicidin and autophagy expression to enhance bacterial survival in macrophages. https:\/\/doi.org\/10.4049\/jimmunol.1801301","DOI":"10.4049\/jimmunol.1801301"},{"key":"4663_CR95","doi-asserted-by":"publisher","unstructured":"Laopanupong T, Prombutara P, Kanjanasirirat P (2021) Lysosome repositioning as an autophagy escape mechanism by Mycobacterium tuberculosis Beijing strain. Sci Rep:1\u201317. https:\/\/doi.org\/10.1038\/s41598-021-83835-4","DOI":"10.1038\/s41598-021-83835-4"},{"key":"4663_CR96","doi-asserted-by":"publisher","unstructured":"Garg R, Borbora SM, Bansia H, Rao S, Singh P (2020) Mycobacterium tuberculosis calcium pump CtpF modulates the autophagosome in an mTOR-dependent manner. 10:1\u201313. https:\/\/doi.org\/10.3389\/fcimb.2020.00461","DOI":"10.3389\/fcimb.2020.00461"},{"key":"4663_CR97","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri3813","volume":"15","author":"RS Wallis","year":"2015","unstructured":"Wallis RS, Hafner R (2015) Advancing host-directed therapy for tuberculosis. Nat Rev Immunol 15:255\u2013263. https:\/\/doi.org\/10.1038\/nri3813","journal-title":"Nat Rev Immunol"},{"key":"4663_CR98","doi-asserted-by":"publisher","unstructured":"Kolloli A, Subbian S (2017) Host-directed therapeutic strategies for tuberculosis. Front Med:4. https:\/\/doi.org\/10.3389\/fmed.2017.00171","DOI":"10.3389\/fmed.2017.00171"},{"key":"4663_CR99","doi-asserted-by":"publisher","unstructured":"Singhal A, Jie L, Kumar P, Hong GS, Leow MKS, Paleja B et al (2014) Metformin as adjunct antituberculosis therapy. Sci Transl Med:6. https:\/\/doi.org\/10.1126\/scitranslmed.3009885","DOI":"10.1126\/scitranslmed.3009885"},{"key":"4663_CR100","doi-asserted-by":"publisher","unstructured":"Krzysztof \u0141, Liber S (2010) Metformin increases phagocytosis and acidifies lysosomal \/ endosomal compartments in AMPK-dependent manner in rat primary microglia:171\u2013186. https:\/\/doi.org\/10.1007\/s00210-009-0477-x","DOI":"10.1007\/s00210-009-0477-x"},{"key":"4663_CR101","doi-asserted-by":"publisher","unstructured":"Padmapriydarsini C, Mamulwar M, Mohan A, Shanmugam P, Gomathy NS, Mane A et al (2022) Randomized trial of metformin with anti-tuberculosis drugs for early sputum conversion in adults with pulmonary tuberculosis. 75:425\u2013434. https:\/\/doi.org\/10.1093\/cid\/ciab964","DOI":"10.1093\/cid\/ciab964"},{"key":"4663_CR102","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/13543784.2017.1384813","volume":"26","author":"M Ghidini","year":"2017","unstructured":"Ghidini M, Petrelli F, Ghidini A, Tomasello G, Hahne JC, Passalacqua R et al (2017) Clinical development of mTor inhibitors for renal cancer. Expert Opin Investig Drugs 26:1229\u20131237. https:\/\/doi.org\/10.1080\/13543784.2017.1384813","journal-title":"Expert Opin Investig Drugs"},{"key":"4663_CR103","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1053\/jlts.2001.24645","volume":"7","author":"P Neuhaus","year":"2001","unstructured":"Neuhaus P, Klupp J, Langrehr JM (2001) mTOR inhibitors: an overview. Liver Transplant 7:473\u2013484. https:\/\/doi.org\/10.1053\/jlts.2001.24645","journal-title":"Liver Transplant"},{"key":"4663_CR104","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1021\/mp4006563","volume":"11","author":"A Gupta","year":"2014","unstructured":"Gupta A, Pant G, Mitra K, Madan J, Chourasia MK, Misra A (2014) Inhalable particles containing rapamycin for induction of autophagy in macrophages infected with Mycobacterium tuberculosis. Mol Pharm 11:1201\u20131207. https:\/\/doi.org\/10.1021\/mp4006563","journal-title":"Mol Pharm"},{"key":"4663_CR105","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s11095-016-1926-0","volume":"33","author":"A Gupta","year":"2016","unstructured":"Gupta A, Sharma D, Meena J, Pandya S, Sachan M, Kumar S et al (2016) Preparation and preclinical evaluation of inhalable particles containing rapamycin and anti-tuberculosis agents for induction of autophagy. Pharm Res 33:1899\u20131912. https:\/\/doi.org\/10.1007\/s11095-016-1926-0","journal-title":"Pharm Res"},{"key":"4663_CR106","doi-asserted-by":"publisher","unstructured":"Bhatt K, Bhagavathula M, Verma S, Timmins GS, Deretic VP, Ellner JJ et al (2021) Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infection. DMM Dis Model Mech:14. https:\/\/doi.org\/10.1242\/dmm.049018","DOI":"10.1242\/dmm.049018"},{"key":"4663_CR107","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4161\/auto.4898","volume":"3","author":"RA Floto","year":"2007","unstructured":"Floto RA, Sarkar S, Perlstein EO, Kampmann B, Schreiber SL, Rubinsztein DC (2007) Erratum: Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington\u2019s disease models and enhance killing of mycobacteria by macrophages (Autophagy). Autophagy 3:620\u2013622. https:\/\/doi.org\/10.4161\/auto.4898","journal-title":"Autophagy"},{"key":"4663_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9072043","volume":"9","author":"D Ashley","year":"2020","unstructured":"Ashley D, Hernandez J, Cao R, To K, Yegiazaryan A, Abrahem R et al (2020) Antimycobacterial effects of everolimus in a human granuloma model. J Clin Med 9:1\u201314. https:\/\/doi.org\/10.3390\/jcm9072043","journal-title":"J Clin Med"},{"key":"4663_CR109","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1515\/bmc-2021-0006","volume":"12","author":"R Cao","year":"2021","unstructured":"Cao R, To K, Kachour N, Beever A, Owens J, Sathananthan A et al (2021) Everolimus-induced effector mechanism in macrophages and survivability of Erdman, CDC1551 and HN878 strains of Mycobacterium tuberculosis infection. Biomol Concepts 12:46\u201354. https:\/\/doi.org\/10.1515\/bmc-2021-0006","journal-title":"Biomol Concepts"},{"key":"4663_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S2213-2600(20)30448-3","volume":"2600","author":"RS Wallis","year":"2021","unstructured":"Wallis RS, Ginindza S, Beattie T, Arjun N, Sebe M, Likoti M et al (2021) Articles Adjunctive host-directed therapies for pulmonary tuberculosis\u00a0: a prospective , open-label , phase 2 , randomised controlled trial. Lancet Respir 2600:1\u201312. https:\/\/doi.org\/10.1016\/S2213-2600(20)30448-3","journal-title":"Lancet Respir"},{"key":"4663_CR111","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1021\/acsbiomaterials.0c00823","volume":"6","author":"A Sharma","year":"2020","unstructured":"Sharma A, Vaghasiya K, Ray E, Gupta P, Gupta UD, Singh AK et al (2020) Targeted pulmonary delivery of the green tea polyphenol epigallocatechin gallate controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and suppressing bacterial burden. ACS Biomater Sci Eng 6:4126\u20134140. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c00823","journal-title":"ACS Biomater Sci Eng"},{"key":"4663_CR112","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1080\/15548627.2015.1075110","volume":"11","author":"R Sultana Rekha","year":"2015","unstructured":"Sultana Rekha R, Rao Muvva SJ, Wan M, Raqib R, Bergman P, Brighenti S et al (2015) Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of mycobacterium tuberculosis in human macrophages. Autophagy 11:1688\u20131699. https:\/\/doi.org\/10.1080\/15548627.2015.1075110","journal-title":"Autophagy"},{"key":"4663_CR113","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1016\/j.febslet.2010.04.050","volume":"584","author":"HH Choi","year":"2010","unstructured":"Choi HH, Shin DM, Kang G, Kim KH, Park JB, Hur GM et al (2010) Endoplasmic reticulum stress response is involved in Mycobacterium tuberculosis protein ESAT-6-mediated apoptosis. FEBS Lett 584:2445\u20132454. https:\/\/doi.org\/10.1016\/j.febslet.2010.04.050","journal-title":"FEBS Lett"},{"key":"4663_CR114","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tube.2015.12.009","volume":"97","author":"Y Cui","year":"2016","unstructured":"Cui Y, Zhao D, Barrow PA, Zhou X (2016) The endoplasmic reticulum stress response: a link with tuberculosis? Tuberculosis 97:52\u201356. https:\/\/doi.org\/10.1016\/j.tube.2015.12.009","journal-title":"Tuberculosis"},{"key":"4663_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3203-9","volume":"18","author":"RS Rekha","year":"2018","unstructured":"Rekha RS, Mily A, Sultana T, Haq A, Ahmed S, Mostafa Kamal SM et al (2018) Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D 3 as host directed therapy. BMC Infect. Dis. 18:1\u201312. https:\/\/doi.org\/10.1186\/s12879-018-3203-9","journal-title":"BMC Infect. Dis."},{"key":"4663_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0138340","volume":"10","author":"A Mily","year":"2015","unstructured":"Mily A, Rekha RS, Kamal SMM, Arifuzzaman ASM, Rahim Z, Khan L et al (2015) Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis: a randomized controlled trial. PLoS One 10:1\u201325. https:\/\/doi.org\/10.1371\/journal.pone.0138340","journal-title":"PLoS One"},{"key":"4663_CR117","doi-asserted-by":"publisher","unstructured":"Keflie TS, N\u00f6lle N, Lambert C, Nohr D, Biesalski K (2015) Vitamin D Deficiencies among tuberculosis patients. Nutrition. https:\/\/doi.org\/10.1016\/j.nut.2015.05.003","DOI":"10.1016\/j.nut.2015.05.003"},{"key":"4663_CR118","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3201\/eid1605.091693","volume":"16","author":"N Talat","year":"2010","unstructured":"Talat N, Perry S, Parsonnet J (2010) Progression 16:853\u2013855. https:\/\/doi.org\/10.3201\/eid1605.091693","journal-title":"Progression"},{"key":"4663_CR119","doi-asserted-by":"publisher","unstructured":"Hong JY, Kim SY, Chung KS, Kim EY, Jung JY, Park MS et al (2014) Association between vitamin D deficiency and tuberculosis in a Korean population. 18:73\u201378. https:\/\/doi.org\/10.5588\/ijtld.13.0536","DOI":"10.5588\/ijtld.13.0536"},{"key":"4663_CR120","doi-asserted-by":"publisher","unstructured":"Jaimni V, Shasty BA, Madhyastha SP, Shetty GV, Acharya RV, Bekur R, Doddamani A (2021) Association of vitamin D deficiency and newly diagnosed pulmonary tuberculosis. Pulmonary medicine 2021:1\u20136. https:\/\/doi.org\/10.1155\/2021\/5285841","DOI":"10.1155\/2021\/5285841"},{"key":"4663_CR121","doi-asserted-by":"publisher","unstructured":"Wen Y, Li L, Deng Z (2022) Calcitriol supplementation accelerates the recovery of patients with tuberculosis who have vitamin D deficiency\u00a0: a randomized , single - blind , controlled clinical trial. BMC Infect Dis:1\u201310. https:\/\/doi.org\/10.1186\/s12879-022-07427-x","DOI":"10.1186\/s12879-022-07427-x"},{"key":"4663_CR122","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0378-8741(95)01331-8","volume":"50","author":"JM Grange","year":"1996","unstructured":"Grange JM, Snell NJC (1996) Activity of bromhexine and ambroxol, semi-synthetic derivatives of vasicine from the Indian shrub Adhatoda vasica, against Mycobacterium tuberculosis in vitro. J Ethnopharmacol 50:49\u201353. https:\/\/doi.org\/10.1016\/0378-8741(95)01331-8","journal-title":"J Ethnopharmacol"},{"key":"4663_CR123","doi-asserted-by":"publisher","unstructured":"Choi SW, Gu Y, Peters RS, Salgame P, Ellner JJ, Timmins GS et al (2018) Ambroxol induces autophagy and potentiates rifampin antimycobacterial activity. Antimicrob Agents Chemother:62. https:\/\/doi.org\/10.1128\/aac.01019-18","DOI":"10.1128\/aac.01019-18"},{"key":"4663_CR124","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/2053369115599090","volume":"21","author":"JH Pickar","year":"2015","unstructured":"Pickar JH, Komm BS (2015) Selective estrogen receptor modulators and the combination therapy conjugated estrogens\/bazedoxifene: a review of effects on the breast. Post Reprod Heal 21:112\u2013121. https:\/\/doi.org\/10.1177\/2053369115599090","journal-title":"Post Reprod Heal"},{"key":"4663_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/msphere.00124-20","volume":"5","author":"Q Ouyang","year":"2020","unstructured":"Ouyang Q, Zhang K, Lin D, Feng CG, Cai Y, Chen X (2020) Bazedoxifene suppresses intracellular Mycobacterium tuberculosis growth by enhancing autophagy. mSphere 5:1\u201310. https:\/\/doi.org\/10.1128\/msphere.00124-20","journal-title":"mSphere"},{"key":"4663_CR126","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/lam.13432","volume":"72","author":"OM Barrientos","year":"2021","unstructured":"Barrientos OM, Ju\u00e1rez E, Gonzalez Y, Castro-Villeda DA, Torres M, Guzm\u00e1n-Beltr\u00e1n S (2021) Loperamide exerts a direct bactericidal effect against M. tuberculosis, M. bovis, M. terrae and M. smegmatis. Lett. Appl. Microbiol 72:351\u2013356. https:\/\/doi.org\/10.1111\/lam.13432","journal-title":"Microbiol"},{"key":"4663_CR127","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.intimp.2018.09.013","volume":"65","author":"E Ju\u00e1rez","year":"2018","unstructured":"Ju\u00e1rez E, Ruiz A, Cortez O, Sada E, Torres M (2018) Antimicrobial and immunomodulatory activity induced by loperamide in mycobacterial infections. Int Immunopharmacol 65:29\u201336. https:\/\/doi.org\/10.1016\/j.intimp.2018.09.013","journal-title":"Int Immunopharmacol"},{"key":"4663_CR128","doi-asserted-by":"publisher","first-page":"7190","DOI":"10.4049\/jimmunol.178.11.7190","volume":"178","author":"AR Martineau","year":"2007","unstructured":"Martineau AR, Wilkinson KA, Newton SM, Floto RA, Norman AW, Skolimowska K et al (2007) IFN-\u03b3- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 178:7190\u20137198. https:\/\/doi.org\/10.4049\/jimmunol.178.11.7190","journal-title":"J Immunol"},{"key":"4663_CR129","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1194\/jlr.RA120000895","volume":"61","author":"N Bruiners","year":"2020","unstructured":"Bruiners N, Dutta NK, Guerrini V, Salamon H, Yamaguchi KD, Karakousis PC et al (2020) The anti-tubercular activity of simvastatin is mediated by cholesterol-driven autophagy via the AMPK-mTORC1-TFEB axis. J Lipid Res 61:1617\u20131628. https:\/\/doi.org\/10.1194\/jlr.RA120000895","journal-title":"J Lipid Res"},{"key":"4663_CR130","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1073\/pnas.0308456101","volume":"101","author":"DE Sleat","year":"2004","unstructured":"Sleat DE, Wiseman JA, El-Banna M, Price SM, Verot L, Shen MM et al (2004) Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A 101:5886\u20135891. https:\/\/doi.org\/10.1073\/pnas.0308456101","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4663_CR131","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1073\/pnas.0910872107","volume":"107","author":"J Xu","year":"2010","unstructured":"Xu J, Dang Y, Ren YR, Liu JO (2010) Cholesterol trafficking is required for mTOR activation in endothelial cells. Proc Natl Acad Sci U S A 107:4764\u20134769. https:\/\/doi.org\/10.1073\/pnas.0910872107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4663_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2019.02097","volume":"10","author":"PDC Guerra-De-Blas","year":"2019","unstructured":"Guerra-De-Blas PDC, Bobadilla-Del-Valle M, Sada-Ovalle I, Estrada-Garc\u00eda I, Torres-Gonz\u00e1lez P, L\u00f3pez-Saavedra A et al (2019) Simvastatin enhances the immune response against Mycobacterium tuberculosis. Front Microbiol 10:1\u201314. https:\/\/doi.org\/10.3389\/fmicb.2019.02097","journal-title":"Front Microbiol"},{"issue":"23","key":"4663_CR133","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(23)00067-1","volume":"23","author":"GB Cross","year":"2023","unstructured":"Cross GB, Sari IP, Kityo C, Lu Q, Pokharkar Y, Moorakonda RB et al (2023) Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial. Lancet Infect Dis 23(23):847\u2013855 https:\/\/doi.org\/http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36966799","journal-title":"Lancet Infect Dis"},{"key":"4663_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0199799","volume":"14","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Ko HJ, Kim SH, Jung YJ (2019) Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages. PLoS One 14:1\u201319. https:\/\/doi.org\/10.1371\/journal.pone.0199799","journal-title":"PLoS One"},{"key":"4663_CR135","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1080\/15548627.2015.1054594","volume":"11","author":"Y Tong","year":"2015","unstructured":"Tong Y, Song F (2015) Intracellular calcium signaling regulates autophagy via calcineurin-mediated TFEB dephosphorylation. Autophagy 11:1192\u20131195. https:\/\/doi.org\/10.1080\/15548627.2015.1054594","journal-title":"Autophagy"},{"key":"4663_CR136","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1016\/j.bbagen.2017.09.010","volume":"1861","author":"S Mawatwal","year":"2017","unstructured":"Mawatwal S, Behura A, Ghosh A, Kidwai S, Mishra A, Deep A et al (2017) Calcimycin mediates mycobacterial killing by inducing intracellular calcium-regulated autophagy in a P2RX7 dependent manner. Biochim Biophys Acta - Gen Subj 1861:3190\u20133200. https:\/\/doi.org\/10.1016\/j.bbagen.2017.09.010","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"4663_CR137","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1053\/j.seminoncol.2011.01.016","volume":"38","author":"JY Blay","year":"2011","unstructured":"Blay JY, Von Mehren M (2011) Nilotinib: a novel, selective tyrosine kinase inhibitor. Semin Oncol 38:S3\u2013S9. https:\/\/doi.org\/10.1053\/j.seminoncol.2011.01.016","journal-title":"Semin Oncol"},{"key":"4663_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.00085","volume":"9","author":"K Mahadik","year":"2018","unstructured":"Mahadik K, Prakhar P, Rajmani RS, Singh A, Balaji KN (2018) c-Abl-TWIST1 epigenetically dysregulate inflammatory responses during mycobacterial infection by co-regulating bone morphogenesis protein and miR27a. Front Immunol 9:1\u201319. https:\/\/doi.org\/10.3389\/fimmu.2018.00085","journal-title":"Front Immunol"},{"key":"4663_CR139","doi-asserted-by":"publisher","unstructured":"Hussain T, Zhao D, Shah SZA, Sabir N, Wang J, Liao Y et al (2019) Nilotinib: a tyrosine kinase inhibitor mediates resistance to intracellular mycobacterium via regulating autophagy. Cells:8. https:\/\/doi.org\/10.3390\/cells8050506","DOI":"10.3390\/cells8050506"},{"key":"4663_CR140","doi-asserted-by":"publisher","unstructured":"Wang J, Sha J, Strong E, Chopra AK, Lee S (2022) FDA-approved amoxapine effectively promotes macrophage control of mycobacteria by inducing autophagy. Microbiology Spectrum 10(5):e02509\u201322. https:\/\/doi.org\/10.1128\/spectrum.02509-22","DOI":"10.1128\/spectrum.02509-22"},{"key":"4663_CR141","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1470-2045(15)70081-1","volume":"16","author":"M Fassnacht","year":"2015","unstructured":"Fassnacht M, Berruti A, Baudin E, Demeure MJ, Gilbert J, Haak H et al (2015) Linsitinib ( OSI-906 ) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma\u00a0: a double-blind , randomised , phase 3 study. Lancet Oncol 16:426\u2013435. https:\/\/doi.org\/10.1016\/S1470-2045(15)70081-1","journal-title":"Lancet Oncol"},{"key":"4663_CR142","doi-asserted-by":"publisher","unstructured":"Bendell JC, Jones SF, Hart L, Spigel DR, Lane CM, Earwood C et al (2015) A phase Ib study of linsitinib ( OSI-906 ), a dual inhibitor of IGF-1R and IR tyrosine kinase , in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer:187\u2013193. https:\/\/doi.org\/10.1007\/s10637-014-0177-3","DOI":"10.1007\/s10637-014-0177-3"},{"key":"4663_CR143","doi-asserted-by":"publisher","unstructured":"Barata P, Cooney M, Tyler A, Wright J, Dreicer R, Garcia JA (2018) A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC). Investigational New Drugs 36:451\u2013457. https:\/\/doi.org\/10.1007\/s10637-018-0574-0","DOI":"10.1007\/s10637-018-0574-0"},{"key":"4663_CR144","doi-asserted-by":"publisher","unstructured":"Wang H, Bi J, Zhang Y, Pan M, Guo Q, Xiao G et al (2022) Human kinase IGF1R\/IR inhibitor linsitinib controls the in vitro and intracellular growth of. https:\/\/doi.org\/10.1021\/acsinfecdis.2c00278","DOI":"10.1021\/acsinfecdis.2c00278"},{"key":"4663_CR145","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1016\/J.APSB.2022.10.001","volume":"12","author":"S Xu","year":"2022","unstructured":"Xu S, Liu X, Zhan P (2022) SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis. Acta Pharm Sin B 12:4519\u20134521. https:\/\/doi.org\/10.1016\/J.APSB.2022.10.001","journal-title":"Acta Pharm Sin B"},{"key":"4663_CR146","doi-asserted-by":"publisher","unstructured":"Caron A, Richard D, Laplante M The roles of mTOR complexes in lipid metabolism:321\u2013350. https:\/\/doi.org\/10.1146\/annurev-nutr-071714-034355","DOI":"10.1146\/annurev-nutr-071714-034355"},{"key":"4663_CR147","doi-asserted-by":"publisher","unstructured":"Houde VP, Bru S, Festuccia WT, Blanchard P, Bellmann K (2010) Deshaies Y, Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue. 59. https:\/\/doi.org\/10.2337\/db09-1324.V.P.H","DOI":"10.2337\/db09-1324.V.P.H"},{"key":"4663_CR148","doi-asserted-by":"publisher","unstructured":"Liu X, Zhang Y, Ni M, Cao H, Signer RAJ, Li D et al (2017) Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation. 19. https:\/\/doi.org\/10.1038\/ncb3527","DOI":"10.1038\/ncb3527"},{"key":"4663_CR149","doi-asserted-by":"publisher","unstructured":"Knight ZA, Schmidt SF, Birsoy K, Tan K, Friedman JM (2014) A critical role for mTORC1 in erythropoiesis and anemia:1\u201317. https:\/\/doi.org\/10.7554\/eLife.01913","DOI":"10.7554\/eLife.01913"},{"key":"4663_CR150","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.oraloncology.2012.11.008","volume":"49","author":"F Martins","year":"2013","unstructured":"Martins F, Augusto M, Oliveira D, Wang Q, Sonis S, Gallottini M et al (2013) A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients. Oral Oncol 49:293\u2013298. https:\/\/doi.org\/10.1016\/j.oraloncology.2012.11.008","journal-title":"Oral Oncol"},{"key":"4663_CR151","doi-asserted-by":"publisher","unstructured":"Rugo HS, Hortobagyi GN, Yao J, Pavel M, Ravaud A, Franz D et al (2016) Meta-analysis of stomatitis in clinical studies of everolimus\u00a0: incidence and relationship with efficacy. https:\/\/doi.org\/10.1093\/annonc\/mdv595","DOI":"10.1093\/annonc\/mdv595"},{"key":"4663_CR152","doi-asserted-by":"publisher","unstructured":"Gallagher EJ, Fierz Y, Vijayakumar A, Haddad N, Yakar S, Leroith D (2011) Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia. 31:3213\u20133222. https:\/\/doi.org\/10.1038\/onc.2011.495","DOI":"10.1038\/onc.2011.495"},{"key":"4663_CR153","doi-asserted-by":"publisher","unstructured":"Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, Boni J et al (2015) Phase II trial of temsirolimus ( CCI-779 ) in recurrent glioblastoma multiforme\u00a0: a North Central Cancer Treatment Group Study. 23. https:\/\/doi.org\/10.1200\/JCO.2005.23.622","DOI":"10.1200\/JCO.2005.23.622"},{"key":"4663_CR154","doi-asserted-by":"publisher","unstructured":"First B, Paper E (2014) Title:617\u2013632. https:\/\/doi.org\/10.1182\/blood-2013-11-535047","DOI":"10.1182\/blood-2013-11-535047"},{"key":"4663_CR155","doi-asserted-by":"publisher","unstructured":"Lampson BL, Kasar SN, Matos TR, Morgan EA, Rassenti L, Davids MS et al (2016) Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity. 128:195\u2013204. https:\/\/doi.org\/10.1182\/blood-2016-03-707133","DOI":"10.1182\/blood-2016-03-707133"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-023-04663-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-023-04663-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T12:03:58Z","timestamp":1697717038000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-023-04663-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,23]]},"references-count":155,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["4663"],"URL":"https:\/\/doi.org\/10.1007\/s10096-023-04663-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,23]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript is a review article that does not require prior approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}